Clinical Trial Update: Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase II clinical study evaluating the efficacy and safety of VC005 in adults with mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• VC005

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED